Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 268

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 268
---
 our future capital needs.
The terms of any offering thereunder will be established at the time of such offering and will be described in a prospectus supplement filed with the SEC prior to the completion of any such offering.

On September 22, 2022, the Company entered into the Purchase Agreement for the 2022 PIPE Financing with the 2022 PIPE Investors for the sale of 3,373,526
shares of our common stock for a price of $12.50 per share and

- 190 -

Pre-FundedWarrants to purchase an aggregate of 2,426,493 shares of our common stock, at a purchase price of $12.4999 per Pre-FundedWarrant. The Pre-FundedWarrants are exercisable at an exercise price of $0.0001 and will be exercisable until exercised in full. The 2022 PIPE Financing closed on September 26, 2022. Aggregate net proceeds, after deducting certain expenses incurred of $0.3 million related to the issuance of the shares, were $72.2 million. The following table presents our cash flows for the periods indicated (in thousands):

|                                                                       |     | 2024 | Nine Months Ended 
     September 30, |   |     | 2023 |         |   |     | 2023 | Year Ended December 31, |   |     | 2022 |          |   |
|:----------------------------------------------------------------------|:----|:-----|------------------:|:--|:----|:-----|--------:|:--|:----|:-----|------------------------:|:--|:----|:-----|---------:|:--|
| Net cash used in operating activities                                 |     | $    |           (44,497 | ) |     | $    | (50,019 | ) |     | $    |                 (59,663 | ) |     | $    |  (49,640 | ) |
| Net cash provided by investing activities                             |     |      |            12,069 |   |     |      |  79,557 |   |     |      |                  83,206 |   |     |      | (132,886 | ) |
| Net cash provided by financing activities                             |     |      |                77 |   |     |      |     246 |   |     |      |                     326 |   |     |      |   72,620 |   |